News

While scores are going up, there is still room for improvement.

FDA warns opioid repackers for "significant violations."

We spoke with Cleveland Clinic’s chief managed care officer about the lessons he’s learned over the years about the transition to value-based care models.

A new study, funded by NIH, provides evidence to support a simple measurement for diagnosing clinically significant airflow obstruction, the key characteristic of COPD.

$100 million would support aid to low-income Americans and veterans in rural areas.

FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.

How technology can help, not cause more headaches for the physicians using it.

Care1st Health Plan Arizona recently unveiled what it calls the first-ever U.S. Medicaid value-based agreement for hep C treatment. Here’s why they say other plans should take notice.

Medicare’s Bundled Payments for Care Improvement Advanced (BPCI-A) model continues to incentivize value-based care.

As projections say healthcare costs will only increase in the future, health execs need to devise strategies to cope.

Newly published research provides insight and direction for health experts seeking to maximize population health and well-being and help alleviate feelings of being disconnected from others.

The current and future treatments for the $10 billion condition.

How employers are looking to tackle health costs.

The future of executive compensation at managed care organizations will be based on incentives.

Three research studies will focus on how clinicians can help prevent firearm injuries.

Why the auto maker sees transportation as an opportunity.

With the push to value-based care, C-suites are adding new roles to foster innovation. What are those new roles, and are they working?

The tech giant and pharmaceutical manufacturer are hoping to develop new solutions together.

The validity of a new large study linking anticholinergic drugs to the risk of dementia has stirred up controversy.

Why health systems need to move toward full-risk or capitation models.

Results from a collaborative study show a significant difference between different ethnic groups and the likelihood of hereditary genetic mutations that are linked to breast cancer.

FDA recalls insulin pumps due to cybersecurity miscommunication.

The states with the highest patient safety records in hospitals.

A study finds that more and more Americans are facing significant mental health issues.

What you need to know about the candidates’ views on healthcare.

How will the executive order on healthcare pricing transparency affect the industry?

How the drug pricing bill could affect pharmacy benefit managers.

They might be the key to patient engagement, but how are patients using them?